Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

CosMED Pharmaceutical (Japan)

InstitutionResearch output, impact & collaborations

CosMED Pharmaceutical (Japan) is a research organisation in Kyoto, JP. OpenAlex records 133 works and 6,582 citations for it. 44 researchers list it as their most recent affiliation.

133
Works
6,582
Citations
44
Researchers
30
Avg h-index

How has CosMED Pharmaceutical (Japan)'s publication output changed over time?

ScholarIQpublication output · 2001–2020

Output grew0% over the shown period — from 1 works in 2001 to 1 in 2020.

1
1
1
2
1
1
1
1
1
1
2001200420062008201220152017201820192020

Who are the most-cited researchers behind CosMED Pharmaceutical (Japan)?

ScholarIQtop researchers by citations
1
Taro Ueno · Neurobiology and Insect Physiology Research
132 works2,555 citations

What are the most-cited papers on CosMED Pharmaceutical (Japan)?

ScholarIQmost cited works
Identification of a dopamine pathway that regulates sleep and arousal in Drosophila
Taro Ueno, Jun Tomita, Hiromu Tanimoto, Keita Endo, Kei Ito, Shoen Kume, Kazuhiko Kume
S2298632. 2012306 Citations
Tamper-Resistant Mobile Health Using Blockchain Technology
Daisuke Ichikawa, Makiko Kashiyama, Taro Ueno
S2764493120. 2017295 CitationsOPEN ACCESS
Single-molecule observation of protein–protein interactions in the chaperonin system
Hideki Taguchi, Taro Ueno, Hisashi Tadakuma, Masasuke Yoshida, Takashi Funatsu
S106963461. 2001116 Citations
DNA Micropatterning on Polycrystalline Diamond via One-Step Direct Amination
Guo-Jun Zhang, Kwang-Soup Song, Yusuke Nakamura, Taro Ueno, Takashi Funatsu, Iwao Ohdomari, Hiroshi Kawarada
S75741262. 2006110 Citations
GroEL Mediates Protein Folding with a Two Successive Timer Mechanism
Taro Ueno, Hideki Taguchi, Hisashi Tadakuma, Masasuke Yoshida, Takashi Funatsu
S156208185. 2004103 CitationsOPEN ACCESS

How much of the research on CosMED Pharmaceutical (Japan) is open access?

ScholarIQopen access share
55%OPEN ACCESS
Gold
27%
Green
0%
Hybrid
9%
Bronze
18%
Closed
45%

Related on ScholarIQ

Advancements in Transdermal Drug Delivery
Top Topic
Dermatology and Skin Diseases
Top Topic
Immunotherapy and Immune Responses
Top Topic
Toxin Mechanisms and Immunotoxins
Top Topic
Cancer survivorship and care
Top Topic
Advanced Drug Delivery Systems
Top Topic
470M+ articles · free account